Rene Sindlev - 17 Mar 2023 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Director, 10%+ Owner
Signature
/s/ Rene Sindlev
Issuer symbol
RENB
Transactions as of
17 Mar 2023
Net transactions value
+$1,000,000
Form type
4
Filing time
21 Mar 2023, 21:39:59 UTC
Previous filing
25 Oct 2022
Next filing
27 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Award $1,000,000 +877,193 +9.1% $1.14 10,545,544 17 Mar 2023 By RS Bio ApS

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Warrant (Right to Buy) Award $0 +438,597 $0.000000 438,597 17 Mar 2023 Common Stock 438,597 $1.14 By RS Bio ApS F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I.